Skip to main content
Figure 1 | BMC Nephrology

Figure 1

From: Effect of chitosan chewing gum on reducing serum phosphorus in hemodialysis patients: a multi-center, randomized, double-blind, placebo-controlled trial

Figure 1

Flow chart of patients enrolled in the study. The following populations were defined. (i) The full analysis set (FAS) included a subset of patients who subsequently received chewing gum and had any of the variables for efficacy measured. (ii) The safety analysis set (SAF) included a subset of patients who received one or more doses of the chewing gum.

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us